
Nipocalimab showed rapid responses within 1 week in warm autoimmune hemolytic anemia (wAIHA), as well as a favorable safety profile.

Irina Murakhovskaya, MD, is the chief of hematology and an associate professor at Montefiore Medical Center in the Bronx, NY.

Nipocalimab showed rapid responses within 1 week in warm autoimmune hemolytic anemia (wAIHA), as well as a favorable safety profile.